| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20035595 | HPV | ENSG00000114200.10 | protein_coding | BCHE | No | No | 590 | P06276 |
| TVIS20036389 | HPV | ENSG00000114200.10 | protein_coding | BCHE | No | No | 590 | P06276 |
| TVIS44015269 | HTLV-1 | ENSG00000114200.10 | protein_coding | BCHE | No | No | 590 | P06276 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | BCHE |
|---|---|
| DrugBank ID | DB00733 |
| Drug Name | Pralidoxime |
| Target ID | BE0002180 |
| UniProt ID | P06276 |
| Regulation Type | activator |
| PubMed IDs | 18825528; 11393267 |
| Citations | Pohanka M, Jun D, Kuca K: In vitro reactivation of trichlorfon-inhibited butyrylcholinesterase using HI-6, obidoxime, pralidoxime and K048. J Enzyme Inhib Med Chem. 2009 Jun;24(3):680-3. doi: 10.1080/14756360802328315.@@Khan S, Hemalatha R, Jeyaseelan L, Oommen A, Zachariah A: Neuroparalysis and oxime efficacy in organophosphate poisoning: a study of butyrylcholinesterase. Hum Exp Toxicol. 2001 Apr;20(4):169-74. |
| Groups | Approved; Vet_approved |
| Direct Classification | N-methylpyridinium compounds |
| SMILES | C[N+]1=C(C=NO)C=CC=C1 |
| Pathways | |
| PharmGKB | PA164744926 |
| ChEMBL | CHEMBL1420 |
